Marella Thorell's Net Worth

$770 Thousand

Estimate Recalculated Nov 7, 2024 04:34PM EST

Who is Marella Thorell

Marella Thorell does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Centessa Pharmaceuticals plc, ESSA Pharma Inc., Vallon Pharmaceuticals, Inc., Evelo Biosciences, Inc., Seres Therapeutics, Inc., and Carisma Therapeutics Inc..

SEC CIK

Marella Thorell's CIK is 0001826323

Past Insider Trading and Trends

2021 was Marella Thorell's most active year for acquiring shares with 6 total transactions. Marella Thorell's most active month to acquire stocks was the month of January. 2023 was Marella Thorell's most active year for disposing of shares, totalling 8 transactions. Marella Thorell's most active month to dispose stocks was the month of October. 2021 saw Marella Thorell paying a total of $20,000.00 for 430,417 shares, this is the most they've acquired in one year. In 2023 Marella Thorell cashed out on 201,845 shares for a total of $25,810.98, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Centessa Pharmaceuticals plc

Chief Accounting Officer
Updated Mar 23, 2022
Form 4
5,210.10%
52.10K
Mar 23, 2022
53.10K
Acquisition
Mar 21
Form 4
67.50K
Feb 03, 2022
67.50K
Grant
Feb 01
Form 4
1.00K
$20.00
$20.00K
Jun 04, 2021
1.00K
Purchase
Jun 02
Form 4
414.42K
Jun 01, 2021
414.42K
Grant
Jan 29 - May 27
Form 3
May 27, 2021
Showing 5 results

ESSA Pharma Inc.

Investor
Updated Mar 28, 2024
Form 4
50.00K
Mar 28, 2024
50.00K
Grant
Mar 25
Form 4
22.50K
Nov 01, 2022
22.50K
Grant
Jun 29
Form 4/A
16.50K
Jan 26, 2021
16.50K
Grant
Dec 11
Form 4
16.50K
Jan 11, 2021
16.50K
Grant
Dec 11
Form 3
Oct 01, 2020
2.88K
Showing 5 results

Vallon Pharmaceuticals, Inc.

Investor
Updated Dec 15, 2022
Form 4
-75.00%
-28.52K
Dec 15, 2022
9.51K
Disposition
Dec 13
Form 4
38.02K
Jul 06, 2022
38.02K
Grant
Jul 01
Form 4
7.50K
Jun 10, 2022
7.50K
Grant
Jun 09
Form 4
15.00K
Feb 12, 2021
15.00K
Grant
Feb 12
Form 3
Feb 09, 2021
Showing 5 results

Evelo Biosciences, Inc.

Chief Financial Officer
Updated Nov 08, 2023
Form 4
-5.92%
-1.81K
$0.33
-$597.63
Nov 08, 2023
28.76K
Sale
ScheduledNov 07 - Nov 08
Form 4
-8.59%
-4.00K
$0.33
-$1.32K
Nov 03, 2023
42.57K
Sale
ScheduledNov 01 - Nov 02
Form 4
37.50K
Sep 13, 2023
37.50K
Grant
Sep 11
Form 4
-8.32%
-2.00K
$9.51
-$19.06K
Aug 09, 2023
22.07K
Sale
Aug 07 - Aug 08
Form 4
-29.64%
-38.53K
$0.13
-$4.84K
May 10, 2023
91.47K
Sale
May 08
Form 4
May 09, 2023
520.00K
Options
May 07
Form 4
520.00K
Feb 09, 2023
520.00K
Grant
Feb 07
Form 4
440.00K
Sep 01, 2022
440.00K
Grant
Sep 01
Form 3
Jul 18, 2022
Showing 9 results

Seres Therapeutics, Inc.

See Remarks
Updated Mar 27, 2024
Form 4
700.00K
Mar 27, 2024
700.00K
Grant
Mar 25
Form 3
Mar 27, 2024
Showing 2 results

Carisma Therapeutics Inc.

Investor
Updated Jul 01, 2024
Form 4
38.70K
Jul 01, 2024
38.70K
Grant
Jul 01
Form 3
Jul 01, 2024
Showing 2 results